// App-Quantinova.ai

2923 : A Propensity Score-Matched Study of Organ Damage in Patients with Systemic Lupus Erythematosus from the BLISS Long-Term Extension Trials Versus the Toronto Lupus Cohort: A Post Hoc Longitudinal Analysis

Researchers

Presenter

  • Murray Urowitz

Principal Investigators

  • Robert L. Ohsfeldt

  • Ron Wielage

  • Kari A. Kelton

  • Yumi Asukai

  • Sulabha Ramachandran

Medical Centers

  • Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada

  • Texas A&M University, TX

  • Medical Decision Modeling Inc., Indianapolis, IN

  • GSK, Uxbridge, Middlesex, United Kingdom,

  • Value Evidence and Outcomes, GlaxoSmithKline, Renaissance Centre, PA

Locations

  • Canada

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • Folate Hydrolase 1

Drug/Treatment

  • Belimumab

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • III

Study Id's

  • N/A

Sponsors

  • GlaxoSmithKline (GSK)

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved